Apart from MMR-deficiency and MMR-proficiency, we speculate that IGSF6 gene is another potential biomarker for responsiveness to immunotherapy due to its significant association with TMB, which is an effective indicator for response prediction to ICI. Here, IGSF6 is linked to hyperinsulinemic hypoglycemia, familial, 4.